Protocol Ledger

NCT07383441 · Phase III · RECRUITING

Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

Interventional Phase III clinical trial protocol NCT07383441 sponsored by SWOG Cancer Research Network in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2026-06-05 Enrollment: 718 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT07383441
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)718 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07383441
Protocol FieldVerified Registry Value
NCT IdentifierNCT07383441
Consolidated Lead SponsorSWOG Cancer Research Network
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment718 participants (ESTIMATED)
Registered Start Date2026-06-05
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI